294 related articles for article (PubMed ID: 20379220)
1. Induced pluripotent stem cells and senescence: learning the biology to improve the technology.
Banito A; Gil J
EMBO Rep; 2010 May; 11(5):353-9. PubMed ID: 20379220
[TBL] [Abstract][Full Text] [Related]
2. The miR-302-Mediated Induction of Pluripotent Stem Cells (iPSC): Multiple Synergistic Reprogramming Mechanisms.
Ying SY; Fang W; Lin SL
Methods Mol Biol; 2018; 1733():283-304. PubMed ID: 29435941
[TBL] [Abstract][Full Text] [Related]
3. A practical and efficient cellular substrate for the generation of induced pluripotent stem cells from adults: blood-derived endothelial progenitor cells.
Geti I; Ormiston ML; Rouhani F; Toshner M; Movassagh M; Nichols J; Mansfield W; Southwood M; Bradley A; Rana AA; Vallier L; Morrell NW
Stem Cells Transl Med; 2012 Dec; 1(12):855-65. PubMed ID: 23283547
[TBL] [Abstract][Full Text] [Related]
4. mTOR-regulated senescence and autophagy during reprogramming of somatic cells to pluripotency: a roadmap from energy metabolism to stem cell renewal and aging.
Menendez JA; Vellon L; Oliveras-Ferraros C; Cufí S; Vazquez-Martin A
Cell Cycle; 2011 Nov; 10(21):3658-77. PubMed ID: 22052357
[TBL] [Abstract][Full Text] [Related]
5. Reverse engineering human neurodegenerative disease using pluripotent stem cell technology.
Liu Y; Deng W
Brain Res; 2016 May; 1638(Pt A):30-41. PubMed ID: 26423934
[TBL] [Abstract][Full Text] [Related]
6. Integration-free reprogramming of human somatic cells to induced pluripotent stem cells (iPSCs) without viral vectors, recombinant DNA, and genetic modification.
Heng BC; Fussenegger M
Methods Mol Biol; 2014; 1151():75-94. PubMed ID: 24838880
[TBL] [Abstract][Full Text] [Related]
7. Robust Differentiation of mRNA-Reprogrammed Human Induced Pluripotent Stem Cells Toward a Retinal Lineage.
Sridhar A; Ohlemacher SK; Langer KB; Meyer JS
Stem Cells Transl Med; 2016 Apr; 5(4):417-26. PubMed ID: 26933039
[TBL] [Abstract][Full Text] [Related]
8. An Insight into Reprogramming Barriers to iPSC Generation.
Haridhasapavalan KK; Raina K; Dey C; Adhikari P; Thummer RP
Stem Cell Rev Rep; 2020 Feb; 16(1):56-81. PubMed ID: 31758374
[TBL] [Abstract][Full Text] [Related]
9. Experimental approaches for the generation of induced pluripotent stem cells.
Sommer CA; Mostoslavsky G
Stem Cell Res Ther; 2010 Aug; 1(3):26. PubMed ID: 20699015
[TBL] [Abstract][Full Text] [Related]
10. The Effect of Fetal Bovine Serum (FBS) on Efficacy of Cellular Reprogramming for Induced Pluripotent Stem Cell (iPSC) Generation.
Kwon D; Kim JS; Cha BH; Park KS; Han I; Park KS; Bae H; Han MK; Kim KS; Lee SH
Cell Transplant; 2016; 25(6):1025-42. PubMed ID: 26450367
[TBL] [Abstract][Full Text] [Related]
11. Induced pluripotent stem cells (iPSCs): molecular mechanisms of induction and applications.
Cerneckis J; Cai H; Shi Y
Signal Transduct Target Ther; 2024 Apr; 9(1):112. PubMed ID: 38670977
[TBL] [Abstract][Full Text] [Related]
12. Progress in the reprogramming of somatic cells.
Ma T; Xie M; Laurent T; Ding S
Circ Res; 2013 Feb; 112(3):562-74. PubMed ID: 23371904
[TBL] [Abstract][Full Text] [Related]
13. The aging signature: a hallmark of induced pluripotent stem cells?
Rohani L; Johnson AA; Arnold A; Stolzing A
Aging Cell; 2014 Feb; 13(1):2-7. PubMed ID: 24256351
[TBL] [Abstract][Full Text] [Related]
14. Highly efficient reprogramming to pluripotency and directed differentiation of human cells with synthetic modified mRNA.
Warren L; Manos PD; Ahfeldt T; Loh YH; Li H; Lau F; Ebina W; Mandal PK; Smith ZD; Meissner A; Daley GQ; Brack AS; Collins JJ; Cowan C; Schlaeger TM; Rossi DJ
Cell Stem Cell; 2010 Nov; 7(5):618-30. PubMed ID: 20888316
[TBL] [Abstract][Full Text] [Related]
15. Role of tumor suppressor genes in the cancer-associated reprogramming of human induced pluripotent stem cells.
Lin YC; Murayama Y; Hashimoto K; Nakamura Y; Lin CS; Yokoyama KK; Saito S
Stem Cell Res Ther; 2014; 5(2):58. PubMed ID: 25157408
[TBL] [Abstract][Full Text] [Related]
16. Application of biomaterials to advance induced pluripotent stem cell research and therapy.
Tong Z; Solanki A; Hamilos A; Levy O; Wen K; Yin X; Karp JM
EMBO J; 2015 Apr; 34(8):987-1008. PubMed ID: 25766254
[TBL] [Abstract][Full Text] [Related]
17. Potential of Induced Pluripotent Stem Cells for Use in Gene Therapy: History, Molecular Bases, and Medical Perspectives.
Fus-Kujawa A; Mendrek B; Trybus A; Bajdak-Rusinek K; Stepien KL; Sieron AL
Biomolecules; 2021 May; 11(5):. PubMed ID: 34067183
[TBL] [Abstract][Full Text] [Related]
18. Induced pluripotency: history, mechanisms, and applications.
Stadtfeld M; Hochedlinger K
Genes Dev; 2010 Oct; 24(20):2239-63. PubMed ID: 20952534
[TBL] [Abstract][Full Text] [Related]
19. Inducing pluripotency in vitro: recent advances and highlights in induced pluripotent stem cells generation and pluripotency reprogramming.
Rony IK; Baten A; Bloomfield JA; Islam ME; Billah MM; Islam KD
Cell Prolif; 2015 Apr; 48(2):140-56. PubMed ID: 25643745
[TBL] [Abstract][Full Text] [Related]
20. Genome integrity: linking pluripotency and tumorgenicity.
Deng W; Xu Y
Trends Genet; 2009 Oct; 25(10):425-7. PubMed ID: 19801173
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
